When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CDTX - Cidara up 30% premarket on mid-stage rezafungin data
Cidara Therapeutics Inc.
Thinly traded micro cap Cidara Therapeutics (NASDAQ:CDTX) is up 30% premarket on light volume on the heels of its announcement of results from the Phase 2 STRIVE study evaluating once-weekly intravenous rezafungin in patients with candidemia and/or invasive candidiasis (yeast infection). The data will be presented this Saturday, October 6, at IDWeek in San Francisco.
More news on: Cidara Therapeutics, Healthcare stocks news, Stocks on the move,